Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 17;13(10):1535.
doi: 10.3390/biom13101535.

Emerging Roles for Dendritic Cells in Heart Failure

Danish Saleh  1 , Rebecca T L Jones  2 , Samantha L Schroth  2 , Edward B Thorp  2   3 , Matthew J Feinstein  1   2
Affiliations
Review

Emerging Roles for Dendritic Cells in Heart Failure

Danish Saleh et al. Biomolecules. .

Abstract

The field of cardio-immunology has emerged from discoveries that define roles for innate and adaptive immune responses associated with myocardial inflammation and heart failure. Dendritic cells (DCs) comprise an important cellular compartment that contributes to systemic immune surveillance at the junction of innate and adaptive immunity. Once described as a singular immune subset, we now appreciate that DCs consist of a heterogeneous pool of subpopulations, each with distinct effector functions that can uniquely regulate the acute and chronic inflammatory response. Nevertheless, the cardiovascular-specific context involving DCs in negotiating the biological response to myocardial injury is not well understood. Herein, we review our current understanding of the role of DCs in cardiac inflammation and heart failure, including gaps in knowledge and clinical relevance.

Keywords: T cells; cardio-immunology; dendritic cells; dilated cardiomyopathy; heart failure; heart-failure with preserved ejection fraction (HFpEF); hypertensive heart disease; ischemic cardiomyopathy; myocardial inflammation; myocarditis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
An enumeration of several forms of myocardial injury associated with a repertoire of dendritic cell and T cell responses leading to myocardial inflammation and the manifestation of clinical disease in the form of heart failure.
See this image and copyright information in PMC

References

    1. Abbas A.K.L., Andrew H., Pillai S. Cellular and Molecular Immunology. 10th ed. Elsevier; Philadelphia, PA, USA: 2021.
    1. Libby P.B., Robert O., Mann D.L., Tomaselli G.F., Bhatt D.L., Soloman S.D., Braunwald E. Braunwald’s Heart Disease. 12th ed. Volume 2. Elsevier; Philadelphia, PA, USA: 2022. p. 2034.
    1. Mann D.L., Topkara V.K., Evans S., Barger P.M. Innate immunity in the adult mammalian heart: For whom the cell tolls. Trans. Am. Clin. Clim. Assoc. 2010;121:34–51. - PMC - PubMed
    1. Nguyen L.S., Cooper L.T., Kerneis M., Funck-Brentano C., Silvain J., Brechot N., Hekimian G., Ammirati E., Ben M’barek B., Redheuil A., et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat. Commun. 2022;13:25. doi: 10.1038/s41467-021-27631-8. - DOI - PMC - PubMed
    1. Everett B.M., Cornel J.H., Lainscak M., Anker S.D., Abbate A., Thuren T., Libby P., Glynn R.J., Ridker P.M. Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation. 2019;139:1289–1299. doi: 10.1161/CIRCULATIONAHA.118.038010. - DOI - PubMed

Publication types